Bladder cancer is any of several types of cancer arising from the epithelial lining of the urinary bladder, a balloon-shaped organ in your pelvic area that stores urine. Tobacco smoking is the main known contributor to urinary bladder cancer. Carcinogens such as nitrosamines are concentrated and excreted in the urine, thereby exposing them to the cells lining the urinary tract. This exposure is prolonged in the bladder (where 95% of urothelial carcinomas arise) but malignant transformation can arise anywhere in the urinary tract, from the renal calyx to the urethral meatus. Bladder cancer can be treated by surgery by removing tumor, tumor and a small portion of the bladder, biological therapy, removing the entire bladder, Chemotherapy, radiation therapy. Belgium had the highest rate of bladder cancer, followed by Lebanon and Malta. About 59 per cent of bladder cancer cases occurred in more developed countries.
Symptoms: The presence of large numbers of abnormal cells in the bone marrow can inhibit the marrow from producing normal healthy blood cells. Symptoms caused by bone marrow failure include paleness, tiredness, shortness of breath, excessive bleeding, and increased susceptibility to infections. Cancer cells can also infiltrate organs such as the lymph nodes, spleen, and liver leading to swelling.
Treatment: Herbal deals in leukemia/blood cancer cure: Certain herbs, at least two varieties of herbs known by the names of 'Garcinia Mangostana' and 'xanothenes' have been found to be effective with respect of leukemia. The herbs and compounds based on them have reflected intrinsic potential of growth inhibiting features.
Statistics: Belgium had the highest rate of bladder cancer in 2012, followed by Lebanon and Turkey. 1 Bladder cancer is the 5th most frequent tumour in males (5.2%). In females, bladder cancer is less frequent (1.7%). Bladder cancer is the 6th most frequent cause of cancer death in males (3.8%) and the 12th most frequent cause of cancer death in females (1.9%). No differences are observed between the regions.Mean age at diagnosis is 73 years in males and 74 years in females.